Decreased reinforcing effects of cocaine following 2 weeks of continuous d-amphetamine treatment in rats

Psychopharmacology

Volumn 206, Issue 3, 2009, Pages 447-456

  Chiodo, Keri A ^a   Roberts, David C S ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Addiction; Agonist therapy; Cocaine; D Amphetamine; Osmotic mini pump; Progressive ratio

Indexed keywords

COCAINE; DEXAMPHETAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COCAINE DEPENDENCE; CONTINUOUS INFUSION; CONTROL GROUP; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG EFFECT; IMPLANTATION; MALE; NONHUMAN; OSMOTIC MINIPUMP; PERFORMANCE; PRIORITY JOURNAL; RAT; REINFORCEMENT; TREATMENT DURATION;

ANIMALS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; COCAINE-RELATED DISORDERS; DEXTROAMPHETAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; MALE; RATS; RATS, SPRAGUE-DAWLEY; REINFORCEMENT SCHEDULE; SELF ADMINISTRATION;

EID: 70349568599     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-009-1622-4     Document Type: Article

References (61)

1. AC Barrett JR Miller JM Dohrmann SB Caine 2004 Effects of dopamine indirect agonists and selective D1-like and D2-like agonists and antagonists on cocaine self-administration and food maintained responding in rats Neuropharmacology 47 Suppl 1 256 273 15464142 10.1016/j.neuropharm.2004.07.007 1:CAS:528:DC%2BD2cXotF2ht7s%3D (Pubitemid 39298269)
2. PL Bonate A Swann PB Silverman 1997 Context-dependent cross-sensitization between cocaine and amphetamine Life Sci 60 L1 L7
3. K Brebner R Phelan DC Roberts 2000 Effect of baclofen on cocaine self-administration in rats reinforced under fixed-ratio 1 and progressive-ratio schedules Psychopharmacology (Berl) 148 314 321 10.1007/s002130050056 1:CAS:528:DC%2BD3cXit1ensbk%3D
4. JR Caplehorn J Bell DG Kleinbaum VJ Gebski 1993 Methadone dose and heroin use during maintenance treatment Addiction 88 119 124 8448501 10.1111/j.1360-0443.1993.tb02769.x 1:STN:280:DyaK3s7pt1OnsA%3D%3D (Pubitemid 23102102)
5. KA Chiodo CM Lack DC Roberts 2008 Cocaine self-administration reinforced on a progressive ratio schedule decreases with continuous d-amphetamine treatment in rats Psychopharmacology (Berl) 200 465 473 10.1007/s00213-008-1222- 8 1:CAS:528:DC%2BD1cXhtFOjsbjK
6. JF Cryan D Hoyer A Markou 2003 Withdrawal from chronic amphetamine induces depressive-like behavioral effects in rodents Biol Psychiatry 54 49 58 12842308 10.1016/S0006-3223(02)01730-4 1:CAS:528:DC%2BD3sXkvF2jsrw%3D (Pubitemid 36776723)
7. DC Des Jarlais 1995 Harm reduction-a framework for incorporating science into drug policy Am J Public Health 85 10 12 7832242 10.2105/AJPH.85.1.10 1:STN:280:DyaK2M7jtlKgug%3D%3D
8. VP Dole ME Nyswander MJ Kreek 1966 Narcotic blockade Arch Intern Med 118 304 309 4162686 10.1001/archinte.118.4.304 1:STN:280:DyaF2s%2Fks1Cjuw%3D%3D
9. MS Eison AS Eison SD Iversen 1983 Two routes of continuous amphetamine administration induce different behavioral and neurochemical effects in the rat Neurosci Lett 39 313 319 6685256 10.1016/0304-3940(83)90319-1 1:CAS:528:DyaL3sXls12ntL4%3D
10. G Ellison W Morris 1981 Opposed stages of continuous amphetamine administration: parallel alterations in motor stereotypies and in vivo spiroperidol accumulation Eur J Pharmacol 74 207 214 7198992 10.1016/0014-2999(81)90532-X 1:CAS:528:DyaL3MXlvFOmtbc%3D (Pubitemid 11002106)
11. MW Emmett-Oglesby JD Lane 1992 Tolerance to the reinforcing effects of cocaine Behav Pharmacol 3 193 200 11224116 1:CAS:528:DyaK3sXmtFOhurY%3D
12. CR Ferrario TE Robinson 2007 Amphetamine pretreatment accelerates the subsequent escalation of cocaine self-administration behavior Eur Neuropsychopharmacol 17 352 357 17029912 10.1016/j.euroneuro.2006.08.005 1:CAS:528:DC%2BD2sXisVCgtrg%3D (Pubitemid 46304208)
13. DA Fiellin GH Friedland MN Gourevitch 2006 Opioid dependence: rationale for and efficacy of existing and new treatments Clin Infect Dis 43 Suppl 4 S173 S177 17109303 10.1086/508180 1:CAS:528:DC%2BD2sXitVamtg%3D%3D (Pubitemid 44901884)
14. MC Fiore 2000 US public health service clinical practice guideline: treating tobacco use and dependence Respir Care 45 1200 1262 11054899 1:STN:280:DC%2BD3crgs1Clsw%3D%3D
15. PM Fleming D Roberts 1994 Is the prescription of amphetamine justified as a harm reduction measure? J R Soc Health 114 127 131 7932481 10.1177/146642409411400303 1:STN:280:DyaK2M%2Fhsl2lug%3D%3D
16. J Grabowski H Rhoades J Schmitz A Stotts LA Daruzska D Creson FG Moeller 2001 Dextroamphetamine for cocaine-dependence treatment: a double-blind randomized clinical trial J Clin Psychopharmacol 21 522 526 11593078 10.1097/00004714-200110000-00010 1:CAS:528:DC%2BD3MXnslSlsro%3D (Pubitemid 32937435)
17. J Grabowski H Rhoades A Stotts K Cowan C Kopecky A Dougherty FG Moeller S Hassan J Schmitz 2004 Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials Neuropsychopharmacology 29 969 981 15039761 10.1038/sj.npp. 1300392 1:CAS:528:DC%2BD2cXjtFOmtL4%3D (Pubitemid 38526797)
18. J Grabowski J Shearer J Merrill SS Negus 2004 Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence Addict Behav 29 1439 1464 15345275 10.1016/j.addbeh.2004.06.018 (Pubitemid 39172183)
19. RP Hammer Jr Y Egilmez MW Emmett-Oglesby 1997 Neural mechanisms of tolerance to the effects of cocaine Behav Brain Res 84 225 239 9079787 10.1016/S0166-4328(97)83332-3 1:CAS:528:DyaK2sXitFWktLg%3D (Pubitemid 27112699)
20. BA Horger MK Giles S Schenk 1992 Preexposure to amphetamine and nicotine predisposes rats to self-administer a low dose of cocaine Psychopharmacology (Berl) 107 271 276 10.1007/BF02245147 1:CAS:528:DyaK38XktVSrsbg%3D
21. SR Hursh 1991 Behavioral economics of drug self-administration and drug abuse policy J Exp Anal Behav 56 377 393 1955823 10.1901/jeab.1991.56-377 1:STN:280:DyaK38%2FmsFWmsA%3D%3D
22. SR Hursh CM Galuska G Winger JH Woods 2005 The economics of drug abuse: a quantitative assessment of drug demand Mol Interv 5 20 28 15731502 10.1124/mi.5.1.6 (Pubitemid 40467772)
23. L Kokkinidis 1984 Effects of chronic intermittent and continuous amphetamine administration on acoustic startle Pharmacol Biochem Behav 20 367 371 6709670 10.1016/0091-3057(84)90272-7 1:CAS:528:DyaL2cXhs1yisrw%3D
24. T Kosten SM Owens 2005 Immunotherapy for the treatment of drug abuse Pharmacol Ther 108 76 85 16023218 10.1016/j.pharmthera.2005.06.009 1:CAS:528:DC%2BD2MXhtVartr3K (Pubitemid 41377120)
25. MJ Kreek 2000 Methadone-related opioid agonist pharmacotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine Ann N Y Acad Sci 909 186 216 10911931 1:CAS:528: DC%2BD3cXlsVOjtb8%3D
26. MJ Kreek FJ Vocci 2002 History and current status of opioid maintenance treatments: blending conference session J Subst Abuse Treat 23 93 105 12220607 10.1016/S0740-5472(02)00259-3 (Pubitemid 36151692)
27. BT Lett 1989 Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine Psychopharmacology (Berl) 98 357 362 10.1007/BF00451687 1:CAS:528:DyaL1MXkslSrtrw%3D (Pubitemid 19162424)
28. SM Li BL Campbell JL Katz 2006 Interactions of cocaine with dopamine uptake inhibitors or dopamine releasers in rats discriminating cocaine J Pharmacol Exp Ther 317 1088 1096 16478825 10.1124/jpet.105.100594 1:CAS:528:DC%2BD28Xlt1eqt7c%3D (Pubitemid 43764112)
29. WJ Lynch WA Heaser ME Carroll 1998 Effects of amphetamine, butorphanol, and morphine pretreatment on the maintenance and reinstatement of cocaine-reinforced responding Exp Clin Psychopharmacol 6 255 263 9725109 10.1037/1064-1297.6.3.255 1:CAS:528:DyaK1cXlslGntbg%3D
30. MT Martin-Iverson BA Lodge 1991 Effects of chronic treatment of rats with "designer" amphetamines on brain regional monoamines Can J Physiol Pharmacol 69 1825 1832 1802356 1:CAS:528:DyaK38XltFersw%3D%3D
31. AT McLellan AI Alterman 1991 Patient treatment matching: a conceptual and methodological review with suggestions for future research NIDA Res Monogr 106 114 135 1656261 1:STN:280:DyaK38%2FhvVWhsQ%3D%3D
32. A Mendrek CD Blaha AG Phillips 1998 Pre-exposure of rats to amphetamine sensitizes self-administration of this drug under a progressive ratio schedule Psychopharmacology (Berl) 135 416 422 10.1007/s002130050530 1:CAS:528: DyaK1cXhs1ymt7Y%3D (Pubitemid 28254849)
33. ID Montoya F Vocci 2008 Novel medications to treat addictive disorders Curr Psychiatry Rep 10 392 398 18803912 10.1007/s11920-008-0063-9
34. SS Negus 2003 Rapid assessment of choice between cocaine and food in rhesus monkeys: effects of environmental manipulations and treatment with d-amphetamine and flupenthixol Neuropsychopharmacology 28 919 931 12637948
35. SS Negus NK Mello 2003 Effects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a progressive-ratio schedule in rhesus monkeys Psychopharmacology (Berl) 167 324 332 1:CAS:528: DC%2BD3sXjs1yns7Y%3D
36. SS Negus NK Mello 2003 Effects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a second-order schedule in rhesus monkeys Drug Alcohol Depend 70 39 52 12681524 10.1016/S0376-8716(02)00339-3 1:CAS:528:DC%2BD3sXis12rtrc%3D (Pubitemid 36385152)
37. LR Nelson G Ellison 1978 Enhanced stereotypies after repeated injections but not continuous amphetamines Neuropharmacology 17 1081 1084 570650 10.1016/0028-3908(78)90045-X 1:CAS:528:DyaE1MXktFeltr0%3D
38. EB Nielsen 1981 Rapid decline of stereotyped behavior in rats during constant one week administration of amphetamine via implanted ALZET osmotic minipumps Pharmacol Biochem Behav 15 161 165 7198262 10.1016/0091-3057(81)90171- 4 1:CAS:528:DyaL3MXlt1Kitb8%3D (Pubitemid 11054608)
39. EB Oleson DC Roberts 2009 Behavioral economic assessment of price and cocaine consumption following self-administration histories that produce escalation of either final ratios or intake Neuropsychopharmacology 34 796 804 18971927 10.1038/npp.2008.195
40. FM Orson BM Kinsey RA Singh Y Wu T Gardner TR Kosten 2008 Substance abuse vaccines Ann N Y Acad Sci 1141 257 269 18991962 10.1196/annals.1441.027 1:CAS:528:DC%2BD1cXhsVOkt7bF
41. RL Peltier DH Li D Lytle CM Taylor MW Emmett-Oglesby 1996 Chronic d-amphetamine or methamphetamine produces cross-tolerance to the discriminative and reinforcing stimulus effects of cocaine J Pharmacol Exp Ther 277 212 218 8613921 1:CAS:528:DyaK28XitlCmt70%3D
42. NR Richardson DC Roberts 1991 Fluoxetine pretreatment reduces breaking points on a progressive ratio schedule reinforced by intravenous cocaine self-administration in the rat Life Sci 49 833 840 1875791 10.1016/0024-3205(91) 90248-A 1:CAS:528:DyaK3MXlslCnurg%3D
43. NR Richardson DC Roberts 1996 Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy J Neurosci Methods 66 1 11 8794935 10.1016/0165-0270(95)00153-0 1:CAS:528:DyaK28Xkt1Olsb4%3D (Pubitemid 26180064)
44. Roberts DCS, Goeders NE (1989) Drug self-administration: experimental methods and determinants. In: Boulton AA, Baker GB, Greenshaw AJ (eds) Neuromethods: psychopharmacology, vol 13. Humana, Clifton, pp 349-398
45. DC Roberts SA Bennett GJ Vickers 1989 The estrous cycle affects cocaine self-administration on a progressive ratio schedule in rats Psychopharmacology (Berl) 98 408 411 10.1007/BF00451696 1:CAS:528:DyaL1MXkslSrtrY%3D (Pubitemid 19162433)
46. DC Roberts MM Andrews GJ Vickers 1996 Baclofen attenuates the reinforcing effects of cocaine in rats Neuropsychopharmacology 15 417 423 8887996 10.1016/0893-133X(96)00002-4 1:CAS:528:DyaK28Xmtlynur4%3D (Pubitemid 26342925)
47. TE Robinson DM Camp 1987 Long-lasting effects of escalating doses of d-amphetamine on brain monoamines, amphetamine-induced stereotyped behavior and spontaneous nocturnal locomotion Pharmacol Biochem Behav 26 821 827 2440058 10.1016/0091-3057(87)90616-2 1:CAS:528:DyaL2sXktlejtLo%3D
48. RB Rothman MH Baumann TE Prisinzano AH Newman 2008 Dopamine transport inhibitors based on GBR12909 and benztropine as potential medications to treat cocaine addiction Biochem Pharmacol 75 2 16 17897630 10.1016/j.bcp.2007.08.007 1:CAS:528:DC%2BD2sXhsVCksLjK (Pubitemid 350235399)
49. RB Rothman BE Blough MH Baumann 2008 Dopamine/serotonin releasers as medications for stimulant addictions Prog Brain Res 172 385 406 18772043 10.1016/S0079-6123(08)00919-9 1:CAS:528:DC%2BD1cXhsV2isbjO
50. CR Rush WW Stoops LR Hays 2009 Cocaine effects during d-amphetamine maintenance: a human laboratory analysis of safety, tolerability and efficacy Drug Alcohol Depend 99 261 271 18926645 10.1016/j.drugalcdep.2008.08.009 1:CAS:528:DC%2BD1cXhsVKltrnK
51. LJ Ryan JC Linder ME Martone PM Groves 1990 Histological and ultrastructural evidence that d-amphetamine causes degeneration in neostriatum and frontal cortex of rats Brain Res 518 67 77 1975218 10.1016/0006-8993(90) 90955-B 1:CAS:528:DyaK3cXltV2iu7k%3D (Pubitemid 20197032)
52. S Schenk B Partridge 1999 Cocaine-seeking produced by experimenter-administered drug injections: dose-effect relationships in rats Psychopharmacology (Berl) 147 285 290 10.1007/s002130051169 1:CAS:528: DC%2BD3cXpslKrsA%3D%3D (Pubitemid 30010549)
53. S Schenk S Snow BA Horger 1991 Pre-exposure to amphetamine but not nicotine sensitizes rats to the motor activating effect of cocaine Psychopharmacology (Berl) 103 62 66 10.1007/BF02244075 1:CAS:528: DyaK3MXpsFSqsQ%3D%3D
54. J Shearer 2008 The principles of agonist pharmacotherapy for psychostimulant dependence Drug Alcohol Rev 27 301 308 18368612 10.1080/09595230801927372
55. J Shearer A Wodak I van Beek RP Mattick J Lewis 2003 Pilot randomized double blind placebo-controlled study of dexamphetamine for cocaine dependence Addiction 98 1137 1141 12873248 10.1046/j.1360-0443.2003.00447.x (Pubitemid 36936500)
56. TS Shippenberg C Heidbreder 1995 Sensitization to the conditioned rewarding effects of cocaine: pharmacological and temporal characteristics J Pharmacol Exp Ther 273 808 815 7752084 1:CAS:528:DyaK2MXlslanu7Y%3D
57. L Shuster G Yu A Bates 1977 Sensitization to cocaine stimulation in mice Psychopharmacology (Berl) 52 185 190 10.1007/BF00439108 1:CAS:528: DyaE2sXks1amurc%3D
58. Stead LF, Perera R, Bullen C, Mant D, Lancaster T (2008) Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev CD000146
59. F Theeuwes SI Yum 1976 Principles of the design and operation of generic osmotic pumps for the delivery of semisolid or liquid drug formulations Ann Biomed Eng 4 343 353 1020825 10.1007/BF02584524 1:CAS:528:DyaE1MXhsVaisbo%3D
60. JA Trafton J Minkel K Humphreys 2006 Determining effective methadone doses for individual opioid-dependent patients PLoS Med 3 e80 16448216 10.1371/journal.pmed.0030080
61. F Vocci W Ling 2005 Medications development: successes and challenges Pharmacol Ther 108 94 108 16083966 10.1016/j.pharmthera.2005.06.010 1:CAS:528:DC%2BD2MXhtVartr3E (Pubitemid 41377122)